Key Insight: Most compounded GLP-1 providers increase your monthly cost as your dose increases. A handful offer flat-rate pricing that stays the same from your starting dose through maintenance. Understanding which model your provider uses prevents billing surprises at month 3 when your dose doubles.
You signed up at $149/month for compounded semaglutide. Four weeks later, your prescriber bumps you from 0.25 mg to 0.5 mg. Your next bill: $199. Eight weeks after that, you hit 1.0 mg. The bill: $249. By the time you reach a 2.4 mg maintenance dose, you're paying $349/month — more than double your starting rate.
This isn't a bait-and-switch — tiered pricing is the industry standard. Higher doses require more active pharmaceutical ingredient per vial, which genuinely costs the pharmacy more. But if nobody told you about the pricing trajectory before you enrolled, it feels like one.
This guide identifies the two pricing models in the market, explains the economics behind each, and names the providers that offer true flat-rate pricing.
Model 1: Tiered Pricing (Industry Standard)
The majority of compounded GLP-1 providers use dose-dependent pricing. Your monthly cost increases as your dose increases, typically in 2 to 4 pricing tiers that correspond to dose ranges. A typical structure looks like:
- Tier 1 (0.25–0.5 mg): $149–$179/month
- Tier 2 (1.0–1.7 mg): $199–$249/month
- Tier 3 (2.4 mg+): $249–$349/month
The economic logic is straightforward: a vial with 10 mg of semaglutide costs the pharmacy more to compound than a vial with 2 mg. Higher doses burn through the vial faster, requiring more frequent shipments or higher-concentration vials. Those costs get passed to the patient.
The Problem With Tiered Pricing
The issue isn't that tiered pricing exists — it's that many providers advertise only the Tier 1 starting price. The "$149/month" you see in the ad becomes $249/month by month 4, and the total cost over your first year is 40% to 60% higher than the starting price suggested.
Transparent providers publish their full pricing tier on their website or enrollment page. Opaque providers reveal tier increases only after you've started treatment — or, worse, after your payment has processed for the higher tier without explicit notification.
Model 2: Flat-Rate Pricing
A smaller number of providers offer flat-rate pricing: the same monthly cost regardless of dose level. You pay the same at 0.25 mg as you do at 2.4 mg. The rate doesn't change as you titrate.
Flat-rate providers absorb the cost differential between low and high doses by averaging across their patient population. Lower-dose patients effectively subsidize higher-dose patients in the pricing model. The provider sets the flat rate at a level that covers average costs across the dose spectrum while maintaining margins.
Gala's Flat-Rate Model
Gala is one of the most visible flat-rate providers in the compounded semaglutide space, advertising $179/month regardless of dose level. This means a patient at 2.4 mg/week pays the same $179 as a patient at 0.25 mg/week — a significant value at higher doses where tiered providers charge $250 or more.
The trade-off: Gala's flat rate of $179 is higher than the cheapest starting-dose pricing from tiered providers (some start at $129–$149). You pay more at the beginning but less at the end. Over a 12-month treatment cycle that includes full titration, the total cost often favors flat-rate pricing — especially for patients who reach and maintain higher doses.
The 12-Month Total Cost Comparison
Consider a patient who titrates from 0.25 mg to 2.4 mg over 16 weeks, then maintains at 2.4 mg for the remainder of the year:
Tiered Provider (representative rates)
- Months 1–2: $149/month = $298
- Months 3–4: $199/month = $398
- Months 5–12: $279/month = $2,232
- 12-month total: $2,928
Flat-Rate Provider at $179/month
- Months 1–12: $179/month = $2,148
- 12-month total: $2,148
In this scenario, the flat-rate provider saves $780 over 12 months — despite having a higher starting price. The savings increase for patients who spend more time at higher doses.
⚠️ Important Caveat: These are illustrative calculations using representative rates, not guaranteed prices from specific providers. Verify current pricing and tier structures directly with each provider before making enrollment decisions based on projected annual costs.
Questions to Ask About Pricing Models
- "Does my monthly price change as my dose increases?"
- "Can you provide the full pricing schedule for all dose levels before I enroll?"
- "Is the price I'm quoted today locked for the duration of my treatment, or subject to change?"
- "If I titrate up and then step back down to a lower maintenance dose, does my price decrease?"
- "What happens to my rate if the provider raises prices after I enroll? Am I grandfathered?"
Frequently Asked Questions
If flat-rate is cheaper long-term, why don't all providers use it?
Flat-rate pricing requires a large enough patient base to average costs across dose levels. Small or new providers can't absorb the cost variability. Additionally, the lower starting price of tiered models is more attractive in advertising — "$149/month" converts better in ads than "$179/month," even if the total annual cost is lower at the flat rate.
Can I switch from a tiered provider to a flat-rate provider mid-treatment?
Yes. Switching providers mid-treatment is straightforward — you'll need a new intake with the new provider, but you can continue at your current dose without re-titrating. The best time to switch is when your tiered pricing hits a level where a flat-rate provider is cheaper.
Do flat-rate providers cut corners on quality to maintain margins at high doses?
Not inherently. Flat-rate pricing is a business model decision, not a quality indicator. The pharmacy, the API source, and the compounding standards are independent of the billing model. Evaluate pharmacy accreditation, testing practices, and regulatory history separately from the pricing structure.
Compare GLP-1 Prices Side by Side
Every provider below offers compounded GLP-1 medications from licensed U.S. pharmacies. Pricing verified as of July 17, 2026 — always confirm current rates before enrolling.